Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D. Aljurf M, et al. Among authors: lu p. Biol Blood Marrow Transplant. 2019 Dec;25(12):2330-2337. doi: 10.1016/j.bbmt.2019.04.012. Epub 2019 Apr 17. Biol Blood Marrow Transplant. 2019. PMID: 31002990 Free article. Review.
Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations.
Aljurf M, Weisdorf D, Hashmi SK, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas M, Ahmed SO, Novitzky N, Srivastava A, Seber A, Elsolh H, Ghavamzadeh A, Confer D, Kodera Y, Greinix H, Szer J, Horowitz M, Niederwieser D. Aljurf M, et al. Among authors: lu p. Hematol Oncol Stem Cell Ther. 2020 Mar;13(1):7-16. doi: 10.1016/j.hemonc.2019.08.002. Epub 2019 Aug 20. Hematol Oncol Stem Cell Ther. 2020. PMID: 31449781 Free article.
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, Wood WA, Brazauskas R, Lehmann L, Pasquini MC, Seber A, Lu PH, Atsuta Y, Riches M, Perales MA, Worel N, Okamoto S, Srivastava A, Chemaly RF, Cordonnier C, Dandoy CE, Wingard JR, Kharfan-Dabaja MA, Hamadani M, Majhail NS, Waghmare AA, Chao N, Kröger N, Shaw B, Mohty M, Niederwieser D, Greinix H, Hashmi SK; WBMT and the CIBMTR Health Services and International Studies Committee. Algwaiz G, et al. Among authors: lu ph. Biol Blood Marrow Transplant. 2020 Dec;26(12):2181-2189. doi: 10.1016/j.bbmt.2020.07.021. Epub 2020 Jul 24. Biol Blood Marrow Transplant. 2020. PMID: 32717432 Free PMC article.
[CART therapy followed by allo-HSCT for patients with B-cell acute lymphoblastic leukemia relapsing after the first hematopoietic stem cell transplantation].
Cao XY, Qiu LY, Zhang JP, Xiong M, Zhao YL, Lu Y, Zhou JR, Wei ZJ, Sun RJ, Liu DY, Zhang X, Yang JF, Lu PH. Cao XY, et al. Among authors: lu y, lu ph. Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):318-323. doi: 10.3760/cma.j.issn.0253-2727.2021.04.009. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33979977 Free PMC article. Chinese.
Methods: Retrospective analysis of the clinical characteristics and prognosis of 41 patients with B-cell ALL who received a second allo-HSCT from October 2015 to June 2020 in Hebei Yanda Lu Daopei Hospital. After the first HSCT, all patients received CD19-CART, or CD22-CAR …
Methods: Retrospective analysis of the clinical characteristics and prognosis of 41 patients with B-cell ALL who received a second allo-HSCT …
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.
Xu LP, Lu PH, Wu DP, Sun ZM, Liu QF, Han MZ, Zhang X, Song YP, Song XM, Hu JD, Huang H, Lai YR, Wan DM, Chen J, Li CF, Xia LH, Wang JB, Liu DH, Huang XJ; Chinese Blood and Marrow Transplantation Registry Group. Xu LP, et al. Bone Marrow Transplant. 2021 Dec;56(12):2940-2947. doi: 10.1038/s41409-021-01431-6. Epub 2021 Aug 25. Bone Marrow Transplant. 2021. PMID: 34433917 Free PMC article.
Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features.
Zhang X, Lu XA, Yang J, Zhang G, Li J, Song L, Su Y, Shi Y, Zhang M, He J, Song D, Lv F, Li W, Wu Y, Wang H, Liu H, Zhou X, He T, Lu P. Zhang X, et al. Among authors: lu xa, lu p. Blood Adv. 2020 May 26;4(10):2325-2338. doi: 10.1182/bloodadvances.2020001466. Blood Adv. 2020. PMID: 32453841 Free PMC article. Clinical Trial.
Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Chen YH, Zhang X, Cheng YF, Chen H, Mo XD, Yan CH, Chen Y, Han W, Sun YQ, Wang Y, Zhang XH, Xu LP, Liu KY, Yang J, Zhang J, Zhang GL, Shi Y, Su YC, Li WQ, Xu L, Song D, Zhang M, Lu P, Huang XJ. Chen YH, et al. Among authors: lu p. Cytotherapy. 2020 Dec;22(12):755-761. doi: 10.1016/j.jcyt.2020.08.002. Epub 2020 Aug 26. Cytotherapy. 2020. PMID: 32861622
Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL, Liu DY, Sun RJ, Zhang JP, Zhou JR, Wei ZJ, Xiong M, Cao XY, Lu Y, Yang JF, Zhang X, Lu DP, Lu P. Zhao YL, et al. Among authors: lu y, lu dp, lu p. Front Immunol. 2021 May 7;12:605766. doi: 10.3389/fimmu.2021.605766. eCollection 2021. Front Immunol. 2021. PMID: 34025637 Free PMC article.
6,618 results